31722-300-32 : NDC 2026 Code

31722-300-32 : Eltrombopag Olamine ( Eltrombopag )

Additionally :

You can get information about “31722-300-32” NDC code in 31722-300-32 in HTML format

HTML | 31722-300-32 in TXT (Plain Text) format

TXT | 31722-300-32 in PDF (Portable Document Format)

PDF | 31722-300-32 in XML format

XML formats.

NDC Code : 31722-300-32 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "31722-300-32",
    "PackageDescription": "1 CARTON in 1 KIT (31722-300-32)  / 30 PACKET in 1 CARTON (31722-300-31)  / 1 POWDER, FOR SUSPENSION in 1 PACKET (31722-300-12) ",
    "NDC11Code": "31722-0300-32",
    "ProductNDC": "31722-300",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Eltrombopag",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Eltrombopag Olamine",
    "DosageFormName": "POWDER, FOR SUSPENSION",
    "RouteName": "ORAL",
    "StartMarketingDate": "20250513",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA216620",
    "LabelerName": "Camber Pharmaceuticals, Inc.",
    "SubstanceName": "ELTROMBOPAG OLAMINE",
    "StrengthNumber": "12.5",
    "StrengthUnit": "mg/1",
    "Pharm_Classes": "Breast Cancer Resistance Protein Inhibitors [MoA], Increased Megakaryocyte Maturation [PE], Increased Platelet Production [PE], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Thrombopoietin Receptor Agonist [EPC], Thrombopoietin Receptor Agonists [MoA], UGT1A1 Inhibitors [MoA], UGT1A3 Inhibitors [MoA], UGT1A4 Inhibitors [MoA], UGT1A6 Inhibitors [MoA], UGT1A9 Inhibitors [MoA], UGT2B15 Inhibitors [MoA], UGT2B7 Inhibitors [MoA]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-05-13",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20250513",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}